This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Neurology  • Stroke  • Lipids and Lipid Disorders  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Annelies W. E. Weverling-Rijnsburger, MD; Iris J. A. M. Jonkers, MD; Eric van Exel, MD; Jacobijn Gussekloo, MD, PhD; Rudi G. J. Westendorp, MD, PhD

Arch Intern Med. 2003;163:1549-1554.

Background  A high total serum cholesterol level does not carry a risk of cardiovascular mortality among people 85 years and older and is related to decreased all-cause mortality. At this old age, there are few data on fractionated lipoprotein levels in the determination of cardiovascular disease risk. The aim of this study was to evaluate the relationships between low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels and mortality from specific causes among people in the oldest age categories.

Methods  Between September 1, 1997, and September 1, 1999, a total of 705 inhabitants in the community of Leiden, the Netherlands, reached the age of 85 years. Among these old people, we initiated a prospective follow-up study to investigate determinants of successful aging. A total of 599 subjects participated (response rate, 87%) and all were followed up to September 2001. Serum levels of total, LDL, and HDL cholesterol were assessed at baseline along with detailed information on comorbid conditions. The main outcome measure was all-cause and specific mortality risk.

Results  During 4 years of follow-up, 152 subjects died. The leading cause of death was cardiovascular disease, with similar mortality risks in all tertiles of LDL cholesterol level. In contrast, low HDL cholesterol level was associated with a 2.0-fold higher risk of fatal cardiovascular disease (95% confidence interval [CI], 1.2-3.2). The mortality risk of coronary artery disease was 2.0 (95% CI, 1.0-3.9) and for stroke it was 2.6 (95% CI, 1.0-6.6). Both low LDL cholesterol and low HDL cholesterol concentrations were associated with an increased mortality risk of infection: 2.7 (95% CI, 1.2-6.2) and 2.4 (95% CI, 1.1-5.6), respectively. The risks were unaffected by comorbidity.

Conclusion  In contrast to high LDL cholesterol level, low HDL cholesterol level is a risk factor for mortality from coronary artery disease and stroke in old age.

From the Section of Gerontology and Geriatrics, Department of General Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Metabolic Syndrome and All-Cause and Cardiovascular Mortality in an Italian Elderly Population: The Progetto Veneto Anziani (Pro.V.A.) Study
Zambon et al.
Diabetes Care 2009;32:153-159.
ABSTRACT | FULL TEXT  

Dairy Products as Essential Contributors of (Micro-) Nutrients in Reference Food Patterns: An Outline for Elderly People
van Staveren et al.
J. Am. Coll. Nutr. 2008;27:747S-754S.
ABSTRACT | FULL TEXT  

Vitamin B12 and Folate and the Risk of Anemia in Old Age: The Leiden 85-Plus Study
den Elzen et al.
Arch Intern Med 2008;168:2238-2244.
ABSTRACT | FULL TEXT  

Plasma Apolipoprotein CI Protects Against Mortality From Infection in Old Age
Berbee et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:122-126.
ABSTRACT | FULL TEXT  

HDL-cholesterol and physical performance: results from the ageing and longevity study in the sirente geographic area (ilSIRENTE Study)
Landi et al.
Age Ageing 2007;36:514-520.
ABSTRACT | FULL TEXT  

High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment
Sanossian et al.
Stroke 2007;38:1104-1109.
ABSTRACT | FULL TEXT  

Apolipoprotein A1 Is a Stronger Prognostic Marker Than Are HDL and LDL Cholesterol for Cardiovascular Disease and Mortality in Elderly Men
Florvall et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006;61:1262-1266.
ABSTRACT | FULL TEXT  

Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Packard et al.
Circulation 2005;112:3058-3065.
ABSTRACT | FULL TEXT  

Phenotypic and Functional Characterization of CD4 T Cells Expressing Killer Ig-Like Receptors
van Bergen et al.
J. Immunol. 2004;173:6719-6726.
ABSTRACT | FULL TEXT  

A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease
Hoffmann et al.
Am. J. Clin. Nutr. 2004;80:633-640.
ABSTRACT | FULL TEXT  

High-Density Lipoprotein and Cardiovascular Risk
Toth
Circulation 2004;109:1809-1812.
FULL TEXT  

Other articles noted
Evid. Based Med. 2004;9:31-32.
FULL TEXT  

Other articles noted: 25 Jul 03 to 7 Nov 03
Evid. Based Nurs. 2004;7:e1-1.
FULL TEXT